Intraocular Lens Models PC10 & PC21
by Advanced Medical Optics, Inc.
PMA P820049
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP820049 | Date11 Mar 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Models PC10 & PC21
- Generic Name
- intraocular lens
- PMA Number
- FDA Product Code
- HQL
- Device Class
- Class III
- Regulation
- 21 CFR Part 886.3600
- Advisory Committee
- Ophthalmic
- FDA Decision
- APPR Approved
- PMA Supplement
- S003
Overview
AI-generated summary, 18 Sep 2026
The Intraocular Lens Models PC10 & PC21 are foldable, single-piece, posterior chamber intraocular lenses designed to replace the natural lens in cataract surgery. These lenses are intended for implantation in the capsular bag or ciliary sulcus to restore visual function after lens extraction.
These lenses are supplied sterile and intended for single-use. They are classified as Class III medical devices under FDA regulations (886.3600) and require a Premarket Approval (PMA P820049). The PC10 and PC21 models are available in specific optical powers and haptics tailored for different surgical needs, with storage and handling per manufacturer instructions to maintain sterility and integrity.
Other devices from Advanced Medical Optics, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are the PC10 and PC21 intraocular lenses reusable or designed for single-use only?
The PC10 and PC21 intraocular lenses are explicitly designed for single-use only and are supplied sterile to ensure patient safety. Since they are classified as Class III devices under FDA regulations, their sterile packaging and intended single-use align with strict medical device standards to prevent cross-contamination and maintain efficacy.
What are the key differences between the PC10 and PC21 models in terms of surgical placement?
Both models are foldable, single-piece posterior chamber intraocular lenses, but their haptics and optical power options are tailored for different surgical needs. The PC10 and PC21 can be implanted either in the capsular bag or the ciliary sulcus, depending on the patient’s anatomy and surgical requirements. The specific design variations allow surgeons to choose based on factors like lens stability, accommodation, or anatomical constraints.
How should these lenses be stored to maintain sterility and integrity before use?
The PC10 and PC21 lenses must be stored and handled strictly per manufacturer instructions to preserve sterility and structural integrity. Since they are supplied sterile, the packaging should remain unopened until immediate preoperative use. Exposure to moisture, extreme temperatures, or contamination risks compromising their sterile state, so adherence to the provided storage guidelines is critical.
What regulatory pathway was followed for FDA approval of these intraocular lenses?
The PC10 and PC21 lenses require Premarket Approval (PMA) under FDA regulations, as they are classified as Class III devices. The approval process (PMA P820049) involved rigorous clinical and safety evaluations, including data submitted to the FDA’s Ophthalmic Devices Advisory Committee (OP). This pathway ensures the lenses meet stringent standards for safety and effectiveness before patient use.